(Q61794203)
Statements
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate (English)
H Joensuu
P Coco
T De Pas
P Bono
S Bosselli
T Jalava
14 August 2007